HUHiroyuki Uchinuma

Hiroyuki Uchinuma

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Hiroyuki Uchinuma has a total of 5 co-authors. Here are the top co-authors by number of shared publications:

  • Hiroki Ishii

    Department of Otolaryngology, Head and Neck Surgery University of Yamanashi Chuo Japan

    1 shared publication
  • Kyoichiro Tsuchiya

    Department of Diabetes and Endocrinology, Graduate School of Interdisciplinary Research, Faculty of Medicine University of Yamanashi Yamanashi Japan

    1 shared publication
  • Miku Yamazaki

    Department of Diabetes and Endocrinology, University of Yamanashi Hospital , Yamanashi 409-3898

    1 shared publication
  • Takeshi Moriguchi

    Department of Emergency and Critical Care Medicine, University of Yamanashi Hospital , Yamanashi 409-3898

    1 shared publication
  • Yuka Yokota

    Department of Pathology, University of Yamanashi Hospital , Yamanashi 409-3898

    1 shared publication

Latest Publications

  • Open Access

    Double filtration plasmapheresis in antithyroid drug-refractory Graves disease with a massive goiter

    by Miku Yamazaki, Hiroyuki Uchinuma, Yuka Yokota, Hiroki Ishii, Takeshi Moriguchi, Kyoichiro Tsuchiya

    We report a case of double filtration plasmapheresis (DFPP) performed in medication-resistant Graves disease (GD) with a massive goiter. A 19-year-old female was diagnosed with GD and initially demonstrated poor medication compliance. She presented with loss of consciousness from hypoxemia due to goiter-related tracheal narrowing. Despite inpatient drug therapy, the thyroid hormone levels remained high. We performed DFPP to control thyrotoxicosis before proceeding with thyroidectomy. After 4 sessions, thyroid hormone levels improved, enabling total thyroidectomy. GD with a large goiter may be refractory to medical therapy. In such cases, DFPP can improve thyroid hormone levels.